Exhale

The official blog of the Lung Institute.

How Common is Emphysema?

23 Aug 2017
| Under Disease Education, Emphysema | Posted by | 2 Comments
How common is emphysema?

The National Emphysema Foundation estimates that 3.1 million Americans have emphysema. This progressive disease usually affects adults over the age of 45 who are long-term smokers or workers in the coal mining, iron ore mining and related industries. It is most often caused by prolonged exposure to tobacco smoke and inhaled irritants such as coal and mineral dusts. Improved safety measures implemented in the 1970’s substantially decreased the incidence of emphysema among miners, but its occurrence has spiked in recent years as a result of less stringent safety standards.

Presently, there is no cure for emphysema. Treatment plans focus on preserving lung function for as long as possible and helping patients breathe more easily. Symptoms may be unnoticeable or very subtle at the onset of emphysema, but as the disease progresses, activities as simple as getting dressed or holding a conversation may cause breathlessness and fatigue. Commonly prescribed treatments for emphysema include supplemental oxygen, inhaled corticosteroids, pulmonary rehabilitation and bronchodilators.

The Lung Institute – the first cellular therapy center in the world to focus exclusively on pulmonary disease – offers an alternative form of care that harnesses the natural healing abilities of the body. Autologous cellular therapy has the potential to actually slow the progression of emphysema and reduce lung inflammation, not just mask its symptoms. In fact, more than 80 percent of patients who receive cellular therapy at the Lung Institute for emphysema and other forms of chronic pulmonary lung disease (COPD) report an improvement in quality of life. Cellular therapy is relatively painless and is performed on an outpatient basis, so patients can rest comfortably in their homes immediately following the procedure.

Contact the Lung Institute at (800) 729-3065 if you would like to explore alternative treatment options for your emphysema. Our devoted medical team looks forward to the opportunity to help you breathe easier.

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.